Non-Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement

Bernardo H.L. Goulart, MD: How Do You Tell Patients That Money Matters in NSCLC Treatment?

Posted: Friday, September 13, 2019

Bernardo H.L. Goulart, MD, of Seattle Cancer Care Alliance, offers practical suggestions for bringing up and discussing the difficult subject of how cost can affect a patient’s outcome for treatment of EGFR- or ALK-positive non–small cell lung cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.